APA (7th ed.) Citation

Jaïs, M., Roblot, P., Maillot, F., Hamidou, M., Enfrein, A., Lescoat, A., . . . Perier, A. (2024). Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: A real-life observational study (BESST study). Rheumatology International, 44(11), 2465. https://doi.org/10.1007/s00296-024-05589-2

Chicago Style (17th ed.) Citation

Jaïs, Marie, Pascal Roblot, François Maillot, Mohamed Hamidou, Antoine Enfrein, Alain Lescoat, Mathieu Puyade, Mickaël Martin, and Amandine Perier. "Belimumab Corticosteroid-sparing Treatment in Systemic Lupus Erythematosus: A Real-life Observational Study (BESST Study)." Rheumatology International 44, no. 11 (2024): 2465. https://doi.org/10.1007/s00296-024-05589-2.

MLA (9th ed.) Citation

Jaïs, Marie, et al. "Belimumab Corticosteroid-sparing Treatment in Systemic Lupus Erythematosus: A Real-life Observational Study (BESST Study)." Rheumatology International, vol. 44, no. 11, 2024, p. 2465, https://doi.org/10.1007/s00296-024-05589-2.